A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers - PubMed (original) (raw)
. 1999 Feb 1;162(3):1827-35.
Affiliations
- PMID: 9973448
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
L C Tan et al. J Immunol. 1999.
Abstract
EBV is a gammaherpesvirus that can establish both nonproductive (latent) and productive (lytic) infections within the cells of its host. Although T cell responses to EBV latent proteins have been well characterized, little is known about the importance of responses to lytic proteins in long term virus carriers. Here we have compared the frequencies of CD8+ T cells specific for EBV latent and lytic Ags in healthy virus carriers, using three techniques: limiting dilution analysis, enzyme-linked immunospot assay, and FACS staining with tetrameric MHC-peptide complexes. T cells specific for EBV lytic protein epitopes were readily detectable in all donors and were usually more abundant than those specific for latent epitopes. We infer that direct T cell control of viral replicative lesions is maintained in long term carriers of EBV and is an important component of the immune response to this virus. Estimates of CD8+ T cell frequencies varied considerably according to methodology; values obtained from MHC-peptide tetramer staining were, on the average, 4.4-fold higher than those obtained from enzyme-linked immunospot assays, which were, in turn, on the average, 5.3-fold higher than those obtained from limiting dilution analysis. Tetramer staining showed that as many as 5.5% circulating CD8+ T cells in a virus carrier were specific for a single EBV lytic protein epitope. Such values are much greater than previously imagined and illustrate how antigenic challenge from a persistent herpesvirus can influence the composition of the host's CD8+ T cell pool.
Similar articles
- Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W. Benninger-Döring G, et al. Virology. 1999 Nov 25;264(2):289-97. doi: 10.1006/viro.1999.9996. Virology. 1999. PMID: 10562493 - A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
Yu HX, Srinivasan N, Ren EE, Chan SH. Yu HX, et al. Tissue Antigens. 2005 Jun;65(6):539-43. doi: 10.1111/j.1399-0039.2005.00403.x. Tissue Antigens. 2005. PMID: 15896201 - Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA. Klatt T, et al. J Rheumatol. 2005 Feb;32(2):239-51. J Rheumatol. 2005. PMID: 15693083 - Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH, Wolf H, Minarovits J. Niller HH, et al. Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review. - Immune surveillance against Epstein-Barr virus.
Moss DJ, Burrows SR, Khanna R, Misko IS, Sculley TB. Moss DJ, et al. Semin Immunol. 1992 Apr;4(2):97-104. Semin Immunol. 1992. PMID: 1377517 Review.
Cited by
- Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance.
Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, Hammerschmitt N, Khan N, Palendira U, Leese AM, Timms JM, Bell AI, Buckley CD, Rickinson AB. Hislop AD, et al. J Clin Invest. 2005 Sep;115(9):2546-55. doi: 10.1172/JCI24810. Epub 2005 Aug 18. J Clin Invest. 2005. PMID: 16110323 Free PMC article. - Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.
Samri A, Haas G, Duntze J, Bouley JM, Calvez V, Katlama C, Autran B. Samri A, et al. J Virol. 2000 Oct;74(19):9306-12. doi: 10.1128/jvi.74.19.9306-9312.2000. J Virol. 2000. PMID: 10982378 Free PMC article. - Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.
Lammoglia Cobo MF, Ritter J, Gary R, Seitz V, Mautner J, Aigner M, Völkl S, Schaffer S, Moi S, Seegebarth A, Bruns H, Rösler W, Amann K, Büttner-Herold M, Hennig S, Mackensen A, Hummel M, Moosmann A, Gerbitz A. Lammoglia Cobo MF, et al. PLoS Pathog. 2022 Apr 22;18(4):e1010206. doi: 10.1371/journal.ppat.1010206. eCollection 2022 Apr. PLoS Pathog. 2022. PMID: 35452490 Free PMC article. - CD8(+) T-cell selection, function, and death in the primary immune response in vivo.
Callan MF, Fazou C, Yang H, Rostron T, Poon K, Hatton C, McMichael AJ. Callan MF, et al. J Clin Invest. 2000 Nov;106(10):1251-61. doi: 10.1172/JCI10590. J Clin Invest. 2000. PMID: 11086026 Free PMC article. - Prospects of a novel vaccination strategy for human gamma-herpesviruses.
Wu TT, Blackman MA, Sun R. Wu TT, et al. Immunol Res. 2010 Dec;48(1-3):122-46. doi: 10.1007/s12026-010-8172-z. Immunol Res. 2010. PMID: 20717741 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials